Modulating the BI-1(TMBIM6)/AKT Signaling Pathway by Licochalcone D Treatment Inhibits Human Melanoma Cell Growth.

IF 6.3 2区 医学 Q1 CHEMISTRY, MEDICINAL
Sun-Young Hwang, Cheol-Jung Lee, Kwanhwan Wi, Young-Kwon Kim, Soo-Bin Nam, Ju Yeon Lee, Goo Yoon, Geul Bang, Jung-Hyun Shim, Mee-Hyun Lee
{"title":"Modulating the BI-1(TMBIM6)/AKT Signaling Pathway by Licochalcone D Treatment Inhibits Human Melanoma Cell Growth.","authors":"Sun-Young Hwang, Cheol-Jung Lee, Kwanhwan Wi, Young-Kwon Kim, Soo-Bin Nam, Ju Yeon Lee, Goo Yoon, Geul Bang, Jung-Hyun Shim, Mee-Hyun Lee","doi":"10.1002/ptr.70089","DOIUrl":null,"url":null,"abstract":"<p><p>Skin cancer is a common type of cancer worldwide with increasing incidence and mortality rates. Phytochemicals, active compounds from plants, are known to exhibit diverse physiological activities with benefits of low cytotoxicity and cost. In this study, we aimed to assess the effects of Licochalcone D (LicoD) derived from Glycyrrhiza inflata on human melanoma cell proliferation and investigate its new underlying mechanisms. To assess the anticancer effects of LicoD on melanoma cells, we conducted MTT and soft agar assay, flow cytometry analysis, Western blots as well as TPA-induced inflammatory mouse model and immunohistochemical analysis. To further uncover the new mechanisms, we assessed MS/MS-based proteomic analysis and verified by knockdown and proliferation assays. LicoD (2.5, 5, and 10 μΜ) dose-dependently inhibited cell growth, induced G2/M phase arrest of cell cycle, and triggered apoptosis in SK-MEL-5 and SK-MEL-28 cells together with regulating the related markers. Importantly, we newly discovered that LicoD suppressed the expression of Bax inhibitor (BI)-1(TMBIM6), an upstream regulator of AKT signaling pathway, as confirmed by informatic analysis and Western blotting. Moreover, we demonstrated by shRNA-mediated knockdown of BI-1(TMBIM6) in melanoma cells that BI-1 plays a critical role in cell proliferation and anchorage-independent growth. Rescue assays using BIA further confirmed the functional contribution of BI-1 to the effects of LicoD. In addition, topical treatment of LicoD reduced epidermal hyperplasia and the expression of pAKT, BI-1 and COX-2 in TPA-induced inflammatory skin tissues. Taken together, our findings provide novel evidences that LicoD exerts anti-melanoma effects by down-regulation of BI-1(TMBIM6)/AKT signaling pathways in vitro and in vivo. These findings suggest essential insights for the future development of strategies in skin cancer prevention and treatment.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytotherapy Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ptr.70089","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Skin cancer is a common type of cancer worldwide with increasing incidence and mortality rates. Phytochemicals, active compounds from plants, are known to exhibit diverse physiological activities with benefits of low cytotoxicity and cost. In this study, we aimed to assess the effects of Licochalcone D (LicoD) derived from Glycyrrhiza inflata on human melanoma cell proliferation and investigate its new underlying mechanisms. To assess the anticancer effects of LicoD on melanoma cells, we conducted MTT and soft agar assay, flow cytometry analysis, Western blots as well as TPA-induced inflammatory mouse model and immunohistochemical analysis. To further uncover the new mechanisms, we assessed MS/MS-based proteomic analysis and verified by knockdown and proliferation assays. LicoD (2.5, 5, and 10 μΜ) dose-dependently inhibited cell growth, induced G2/M phase arrest of cell cycle, and triggered apoptosis in SK-MEL-5 and SK-MEL-28 cells together with regulating the related markers. Importantly, we newly discovered that LicoD suppressed the expression of Bax inhibitor (BI)-1(TMBIM6), an upstream regulator of AKT signaling pathway, as confirmed by informatic analysis and Western blotting. Moreover, we demonstrated by shRNA-mediated knockdown of BI-1(TMBIM6) in melanoma cells that BI-1 plays a critical role in cell proliferation and anchorage-independent growth. Rescue assays using BIA further confirmed the functional contribution of BI-1 to the effects of LicoD. In addition, topical treatment of LicoD reduced epidermal hyperplasia and the expression of pAKT, BI-1 and COX-2 in TPA-induced inflammatory skin tissues. Taken together, our findings provide novel evidences that LicoD exerts anti-melanoma effects by down-regulation of BI-1(TMBIM6)/AKT signaling pathways in vitro and in vivo. These findings suggest essential insights for the future development of strategies in skin cancer prevention and treatment.

甘草查尔酮D调控BI-1(TMBIM6)/AKT信号通路抑制人黑色素瘤细胞生长
皮肤癌是世界范围内常见的一种癌症,发病率和死亡率都在不断上升。植物化学物质是来自植物的活性化合物,具有多种生理活性,具有低细胞毒性和低成本的优点。在这项研究中,我们旨在评估从甘草中提取的Licochalcone D (LicoD)对人黑色素瘤细胞增殖的影响,并探讨其新的潜在机制。为了评估LicoD对黑色素瘤细胞的抗癌作用,我们进行了MTT和软琼脂实验、流式细胞术分析、Western blots以及tpa诱导的炎症小鼠模型和免疫组织化学分析。为了进一步揭示新的机制,我们评估了基于MS/MS的蛋白质组学分析,并通过敲低和增殖试验进行了验证。在SK-MEL-5和SK-MEL-28细胞中,LicoD(2.5、5和10 μΜ)呈剂量依赖性地抑制细胞生长,诱导细胞周期G2/M期阻滞,并通过调节相关标志物触发细胞凋亡。重要的是,我们新发现LicoD抑制了Bax抑制剂(BI)-1(TMBIM6)的表达,这是AKT信号通路的上游调节因子,经信息分析和Western blotting证实。此外,我们通过shrna介导的黑素瘤细胞中BI-1(TMBIM6)的敲低证明BI-1在细胞增殖和非锚定生长中起关键作用。BIA的抢救试验进一步证实了BI-1对LicoD作用的功能贡献。此外,局部使用LicoD可以减少表皮增生,降低tpa诱导的炎症皮肤组织中pAKT、BI-1和COX-2的表达。综上所述,我们的研究结果提供了新的证据,证明LicoD通过下调BI-1(TMBIM6)/AKT信号通路在体外和体内发挥抗黑色素瘤作用。这些发现为皮肤癌预防和治疗策略的未来发展提供了重要的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Phytotherapy Research
Phytotherapy Research 医学-药学
CiteScore
12.80
自引率
5.60%
发文量
325
审稿时长
2.6 months
期刊介绍: Phytotherapy Research is an internationally recognized pharmacological journal that serves as a trailblazing resource for biochemists, pharmacologists, and toxicologists. We strive to disseminate groundbreaking research on medicinal plants, pushing the boundaries of knowledge and understanding in this field. Our primary focus areas encompass pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine. We actively encourage submissions on the effects of commonly consumed food ingredients and standardized plant extracts. We welcome a range of contributions including original research papers, review articles, and letters. By providing a platform for the latest developments and discoveries in phytotherapy, we aim to support the advancement of scientific knowledge and contribute to the improvement of modern medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信